Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...
AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...
The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest ...
Most Americans likely will not benefit immediately from efforts to lower prescription prices. Administration officials expect ...
As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on ...
AbbVie (ABBV) has reached a three-year deal with the Trump administration to reduce drug prices and invest $100 billion in ...
In the closing months of 2025, President Donald Trump’s effort to reshape how Americans pay for prescription drugs has taken clearer form. What started as a campaign threat to slap tariffs on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback